TRDA

13.06

2.92% 0.37

Vorhandelsmarkt: 13.39 0.33 +2.53%

Entrada Therapeutics Inc (TRDA)

Überblick Nachrichten Preisverlauf Financials Forum Prognose

Schlusskurs vom Vortag:

$12.69

Offen:

$12.83

24-Stunden-Volumen:

93,433

Relative Volume:

0.80

Marktkapitalisierung:

$488.70M

Einnahmen:

$239.40M

Nettoeinkommen (Verlust:

$104.44M

KGV:

4.4122

EPS:

2.96

Netto-Cashflow:

$-18.50M

1W Leistung:

+4.56%

1M Leistung:

-25.75%

6M Leistung:

-23.09%

1J Leistung:

-10.85%

1-Tages-Spanne:

$12.71

$13.15

1-Wochen-Bereich:

$12.02

$13.15

52-Wochen-Spanne:

$11.35

$21.79

Entrada Therapeutics Inc Stock (TRDA) Company Profile

Firmenname

Entrada Therapeutics Inc

Sektor

Healthcare (1176)

Branche

Biotechnology (685)

Telefon

857-305-1825

Adresse

ONE DESIGN CENTER PLACE, BOSTON

Mitarbeiter

177

Twitter

Nächster Verdiensttermin

2024-08-12

Neueste SEC-Einreichungen

TRDA's Discussions on Twitter

Vergleichen Sie TRDA mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
TRDA Entrada Therapeutics Inc	13.06	488.70M	239.40M	104.44M	-18.50M	2.96
VRTX Vertex Pharmaceuticals Inc	427.89	110.19B	10.63B	-479.80M	-1.35B	-1.99
REGN Regeneron Pharmaceuticals Inc	687.80	75.58B	13.85B	4.65B	3.32B	40.41
ARGX Argen X Se Adr	647.39	38.71B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	264.99	34.18B	2.09B	-332.26M	16.06M	-2.62
BNTX Biontech Se Adr	117.25	28.11B	3.30B	-501.07M	1.03B	-2.1146

Entrada Therapeutics Inc Stock (TRDA) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-12-06	Eingeleitet	ROTH MKM	Buy
2024-01-05	Eingeleitet	Oppenheimer	Outperform
2023-04-03	Eingeleitet	H.C. Wainwright	Buy

Entrada Therapeutics Inc Aktie (TRDA) Neueste Nachrichten

Jan 16, 2025

Barclays PLC Buys 30,585 Shares of Entrada Therapeutics, Inc. (NASDAQ:TRDA) - Defense World

Jan 16, 2025

Jan 15, 2025

Entrada Therapeutics : Corporate Presentation - Marketscreener.com

Jan 15, 2025

Jan 12, 2025

Entrada Therapeutics, Inc. (NASDAQ:TRDA) Shares Sold by Jane Street Group LLC - Defense World

Jan 12, 2025

Jan 11, 2025

The Market Doesn't Like What It Sees From Entrada Therapeutics, Inc.'s (NASDAQ:TRDA) Revenues Yet As Shares Tumble 26% - Simply Wall St

Jan 11, 2025

Jan 10, 2025

Entrada Therapeutics (NASDAQ:TRDA) Trading Down 7.6%Here's Why - MarketBeat

Jan 10, 2025

Jan 02, 2025

Geode Capital Management LLC Raises Position in Entrada Therapeutics, Inc. (NASDAQ:TRDA) - MarketBeat

Jan 02, 2025

Geode Capital Management LLC Has $9.21 Million Stake in Entrada Therapeutics, Inc. (NASDAQ:TRDA) - Defense World

Jan 02, 2025

Jan 01, 2025

Barclays PLC Increases Holdings in Entrada Therapeutics, Inc. (NASDAQ:TRDA) - Defense World

Jan 01, 2025

Entrada Therapeutics, Inc. (NASDAQ:TRDA) Shares Bought by Barclays PLC - MarketBeat

Jan 01, 2025

Dec 30, 2024

Best Momentum Stocks to Buy for December 30th - Yahoo Finance

Dec 30, 2024

Dec 28, 2024

State Street Corp Has $7.50 Million Stock Position in Entrada Therapeutics, Inc. (NASDAQ:TRDA) - Defense World

Dec 28, 2024

Where are the Opportunities in (TRDA) - Stock Traders Daily

Dec 28, 2024

Dec 22, 2024

Entrada Therapeutics, Inc. (NASDAQ:TRDA) Shares Bought by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World

Dec 22, 2024

Dec 18, 2024

Entrada Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference - Marketscreener.com

Dec 18, 2024

Dec 17, 2024

(TRDA) Proactive Strategies - Stock Traders Daily

Dec 17, 2024

Dec 16, 2024

Recent Price Trend in Entrada Therapeutics (TRDA) is Your Friend, Here's Why - MSN

Dec 16, 2024

Dec 15, 2024

Charles Schwab Investment Management Inc. Has $2.97 Million Position in Entrada Therapeutics, Inc. (NASDAQ:TRDA) - Defense World

Dec 15, 2024

Dec 13, 2024

XTX Topco Ltd Takes $634,000 Position in Entrada Therapeutics, Inc. (NASDAQ:TRDA) - MarketBeat

Dec 13, 2024

Dec 10, 2024

Entrada Therapeutics, Inc. (NASDAQ:TRDA) Shares Sold by Fmr LLC - MarketBeat

Dec 10, 2024

Dec 09, 2024

Is Entrada Therapeutics, Inc.'s (NASDAQ:TRDA) Recent Stock Performance Tethered To Its Strong Fundamentals? - Simply Wall St

Dec 09, 2024

Dec 08, 2024

Entrada Therapeutics (NASDAQ:TRDA) Upgraded at Roth Capital - Defense World

Dec 08, 2024

Dec 07, 2024

Roth Mkm Begins Coverage on Entrada Therapeutics (NASDAQ:TRDA) - MarketBeat

Dec 07, 2024

Roth MKM starts ‘overlooked’ Entrada Therapeutics with Buy rating - Yahoo Finance

Dec 07, 2024

Entrada Therapeutics, Inc. (NASDAQ:TRDA) Shares Purchased by Janus Henderson Group PLC - MarketBeat

Dec 07, 2024

Jacobs Levy Equity Management Inc. Has $3.23 Million Stock Position in Entrada Therapeutics, Inc. (NASDAQ:TRDA) - MarketBeat

Dec 07, 2024

Dec 03, 2024

Insider Sell Alert: Natarajan Sethuraman Sells Shares of Entrada Therapeutics Inc (TRDA) - GuruFocus.com

Dec 03, 2024

Entrada Therapeutics CFO sells shares worth nearly $120,000 By Investing.com - Investing.com Nigeria

Dec 03, 2024

Entrada Therapeutics president sells $320,619 in stock By Investing.com - Investing.com Nigeria

Dec 03, 2024

Entrada Therapeutics CFO sells shares worth nearly $120,000 - Investing.com India

Dec 03, 2024

Entrada Therapeutics president sells $320,619 in stock - Investing.com

Dec 03, 2024

Entrada Therapeutics stock hits 52-week high at $20.5 By Investing.com - Investing.com Canada

Dec 03, 2024

Nov 28, 2024

Massachusetts Financial Services Co. MA Invests $1.11 Million in Entrada Therapeutics, Inc. (NASDAQ:TRDA) - MarketBeat

Nov 28, 2024

Nov 26, 2024

Entrada Therapeutics (TRDA) Is a Great Choice for 'Trend' Investors, Here's Why - MSN

Nov 26, 2024

(TRDA) Investment Analysis and Advice - Stock Traders Daily

Nov 26, 2024

Connor Clark & Lunn Investment Management Ltd. Has $2.22 Million Holdings in Entrada Therapeutics, Inc. (NASDAQ:TRDA) - MarketBeat

Nov 26, 2024

Nov 17, 2024

Los Angeles Capital Management LLC Makes New $542,000 Investment in Entrada Therapeutics, Inc. (NASDAQ:TRDA) - MarketBeat

Nov 17, 2024

Nov 15, 2024

Insider Sale at Entrada Therapeutics Inc (TRDA) by President of Research & Development - GuruFocus.com

Nov 15, 2024

Nov 13, 2024

500: Something went wrong - Investing.com UK

Nov 13, 2024

Entrada Therapeutics stock hits 52-week high at $20.28 By Investing.com - Investing.com Canada

Nov 13, 2024

Nov 11, 2024